WNS (Holdings) Ltd presses for scalable competitive intelligence in pharma sector with Capgemini collaboration

WNS (Holdings) Ltd presses for scalable competitive intelligence in pharma sector with Capgemini collaboration
WNS targets pharma intelligence scaling

WNS (Holdings) Ltd is addressing the major challenge of scaling competitive intelligence across the pharmaceutical value chain. The company, together with Capgemini, plans to share insights at the upcoming Pharma CI 2026 event, focusing on strategies for building smarter and more scalable competitive intelligence operations in the industry.

This collaboration aims to help pharmaceutical companies outpace evolving market dynamics and leverage intelligence to achieve a competitive edge. Participants are encouraged to take part in the conversation to help shape future-ready intelligence solutions for the sector.

WNS (Holdings) Ltd has recently expanded its sector focus, launching Modern Airline Retailing CoEs to help airlines unify systems and drive operational efficiency. The company has also outlined how high-touch order management can slow scaling for retail enterprises, offering new solutions in that space. These initiatives reflect WNS’s ongoing efforts to address operational challenges across industries.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.